News

Thank you for another extraordinary year, replete with extraordinary work!

The Winter 2021 newsletter for Lung-MAP participating sites is now available.

Combo with immunotherapy drug can be effective in patients who are not good candidates for chemo

Analyses presented at ASH 2021 find statistical models can predict risk of early death with non-intensive AML therapy

Results at SABCS show assay has prognostic value that complements value of recurrence score in postmenopausal patients

Effectively joining SWOG’s work: A how-to for young investigators

RxPONDER finds postmenopausal women with HR+, HER2- breast cancer with 1-3 involved nodes and an RS of 25 or less can safely skip chemo